Enrollment completed in Phase III Copaxone MS trial
Enrollment completed in Phase III Copaxone MS trial
Teva Pharmaceutical Industries Ltd. today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial. This international Phase III trial in patients with relapsing-remitting multiple sclerosis (RRMS), is designed to examine the efficacy, safe... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2031 Views
-
Last post by NHE
-
- 0 Replies
- 10627 Views
-
Last post by NHE
-
- 0 Replies
- 1102 Views
-
Last post by frodo
-
- 0 Replies
- 1455 Views
-
Last post by NHE
-
- 1 Replies
- 2700 Views
-
Last post by Tif
-
- 2 Replies
- 3851 Views
-
Last post by DIM
-
- 0 Replies
- 2191 Views
-
Last post by NHE
-
- 0 Replies
- 10779 Views
-
Last post by NHE
-
- 0 Replies
- 2171 Views
-
Last post by NHE